The effect of early administration of combined multi-strain and multi-species probiotics on gastrointestinal morbidities and mortality in preterm infants: A randomized controlled trial in a tertiary care unit.

Güney-Varal İ, Köksal N, Özkan H, Bağcı O, Doğan P. The effect of early administration of combined multi-strain and multi-species probiotics on gastrointestinal morbidities and mortality in preterm infants: A randomized controlled trial in a tertiary care unit. Turk J Pediatr 2017; 59: 13-19. Necrotizing enterocolitis (NEC) is a gastrointestinal emergency of the neonatal period. The aim of this study was to demonstrate the use of multistrain and multispecies probiotic on gastrointestinal morbidities and mortality. The study was organized as a randomized controlled, prospective study in premature infants (≤32 week and ≤1500 gram). The ready commercial preparations which contain multi-combined probiotics of Lactobacillus rhamnosus (4.1x10⁸ cfu) + Lactobacillus casei (8.2x10⁸ cfu) + Lactobacillus plantorum (4.1x10⁸ cfu) + Bifidobacterium animalis (4.1x10⁸ cfu) together with 383 mg of fructooligosaccharides and 100 mg of galactooligosaccharides as the prebiotic content, was administered enterally to the probiotic group (n=70); control group constituted of 40 preterms. Primary outcomes of the present study were ≥ Stage 2 NEC and the mortality. Secondary outcomes were culture-proven sepsis and days to reach full enteral feeding. All cases of NEC were seen in group 2 as 3.6% (n=4) of all infants. The mortality was found to be 1.4% (n=1) in Group 1 and 22.5% (n=9) in Group 2. The incidence of NEC and the mortality rate were found to be significantly lower in Group 1 (p=0.016, p=0.001, respectively). In Group 1, the NEC-related mortality rate and sepsis-related mortality rate were significantly lower than that of the control group (p=0.046, p=0.023). In this study, we showed that using probiotic strains in combined multistrain and multispecies forms at higher doses and for prolonged duration had positive effects on gastrointestinal complications, sepsis and mortality in premature infants.

[1]  M. Underwood,et al.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant. , 2016, Clinical therapeutics.

[2]  D. Doherty,et al.  Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study , 2016, PloS one.

[3]  K. Costeloe,et al.  Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial , 2016, The Lancet.

[4]  B. Abdulkadir,et al.  Routine Use of Probiotics in Preterm Infants: Longitudinal Impact on the Microbiome and Metabolome , 2016, Neonatology.

[5]  G. Greisen,et al.  Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies , 2015, Neonatology.

[6]  K. Barrington,et al.  Cohort study of probiotics in a North American neonatal intensive care unit. , 2014, The Journal of pediatrics.

[7]  R. Parker.  Probiotic Guideline for Necrotizing Enterocolitis Prevention in Very Low-Birth-Weight Neonates , 2014, Advances in neonatal care : official journal of the National Association of Neonatal Nurses.

[8]  M. Oncel,et al.  Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial , 2013, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[9]  T. Gursoy,et al.  Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. , 2013, Early human development.

[10]  C. Morley,et al.  Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial , 2013, Pediatrics.

[11]  G. Demirel,et al.  Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study , 2013, Acta paediatrica.

[12]  J. Perry,et al.  Development of the Preterm Gut Microbiome in Twins at Risk of Necrotising Enterocolitis and Sepsis , 2013, PloS one.

[13]  M. Rojas,et al.  Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants , 2012, Pediatrics.

[14]  L. Fernández-Carrocera,et al.  Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis , 2012, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[15]  S. Patole,et al.  Evidence-based guidelines for use of probiotics in preterm neonates , 2011, BMC medicine.

[16]  M. Bulsara,et al.  Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates , 2010, Pediatrics.

[17]  R. Soll.  Probiotics: Are We Ready for Routine Use? , 2010, Pediatrics.

[18]  F. Pohlandt,et al.  Effect of Bifidobacterium lactis on the Incidence of Nosocomial Infections in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial , 2010, Neonatology.

[19]  S. Imam,et al.  Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. , 2010, Pakistan journal of biological sciences : PJBS.

[20]  B. Berger,et al.  Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. , 2009, The American journal of clinical nutrition.

[21]  M. Sarkar,et al.  Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. , 2008, Journal of tropical pediatrics.

[22]  Chyong-hsin Hsu,et al.  Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Preterm Infants: A Multicenter, Randomized, Controlled Trial , 2008, Pediatrics.

[23]  Tomohiko Nakamura,et al.  Risk factors for nosocomial infection in the neonatal intensive care unit by the Japanese Nosocomial Infection Surveillance (JANIS). , 2008, Acta medica Okayama.

[24]  M. Mostert,et al.  Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Kliegman.  Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. , 2005, The Journal of pediatrics.

[26]  C. Hammerman,et al.  Germ warfare: probiotics in defense of the premature gut. , 2004, Clinics in perinatology.

[27]  M. Gänzle.  Reutericyclin: biological activity, mode of action, and potential applications , 2004, Applied Microbiology and Biotechnology.

[28]  C. Dani,et al.  Probiotics Feeding in Prevention of Urinary Tract Infection, Bacterial Sepsis and Necrotizing Enterocolitis in Preterm Infants , 2002, Neonatology.

[29]  Robert M. Kliegman,et al.  Necrotizing Enterocolitis: Treatment Based on Staging Criteria , 1986, Pediatric Clinics of North America.

[30]  Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula , 2016, Pediatric Research.

[31]  W. Bernardo,et al.  Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. , 2013, Jornal de pediatria.

[32]  Yimin Zhu,et al.  Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. , 2012, Journal of pediatric surgery.

[33]  D. Bassler,et al.  Probiotics for prevention of necrotizing enterocolitis in preterm infants (Review) , 2014 .

[34]  G. Krasan.  Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates , 2006 .